Michigan State University
East Lansing, Michigan, 48824, United States
NCT Number: NCT01910350
1) To determine if the Kin KeeperSM Cancer Prevention Intervention increases first time and appropriately timed breast cancer screening rates among Black, Latina and Arab women; 2) To determine if the Kin KeeperSM Cancer Prevention Intervention increase first time and appropriately time cervical cancer screening rates among Black, Latina and Arab women; 3) To measure functional cancer literacy over time at the individual and familial level and 4) Assess rates of healthcare utilization cost among women in the Kin KeeperSM intervention and control-comparison groups.
Looking for future studies?
Notify Me21 year–70 year
Female
Interventional
Not applicable
East Lansing, Michigan, 48824, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline through 36 months.
Participants will complete measures every 6 months (baseline, 12 mo., 18 mo., 24 mo., 30 mo. & 36 mo.)to measure increases in screening rates for experimental vs. control group.
Time frame: Baseline-36 months.
Do participants have a higher breast and cervical cancer literacy rates post intervention and over 36 months than control group as well as better retention?
Michigan State University
Other
Acronym: KinKeeper
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06106165
Bowel Cancer, Breast Cancer
Glasgow, Scotland, United Kingdom
View Trial DetailsNCT05035173
Breast Cancer, Breast Diseases
Cork, Ireland
View Trial DetailsNCT06846099
Adnexal Diseases, Breast Cancer
Beijing, China
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial Details